Protuoso Biosciences is an innovative biotech specializing in engineering novel protein therapeutics for the treatment of complex diseases. Leveraging an R&D platform that incorporates computational protein design, synthetic biology and machine learning, the company is able to drastically reduce the design space and accelerate the discovery of best-in-class and first-in-class protein therapeutics. Protuoso is led by industry veterens in biotech who have raised a combined hundreds of millions of dollars and successfully taken drug candidates from discovery to late stage clinical trials